AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patients.

Saved in:
Bibliographic Details
Title: AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patients.
Authors: Knutson TP; Minnesota Supercomputing Institute, University of Minnesota, Minneapolis, MN, USA., Luo B; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA., Kobilka A; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA., Lyman J; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.; Graduate Program in Molecular, Cellular, and Developmental Biology and Genetics, University of Minnesota, Minneapolis, MN, USA., Guo S; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA., Munro SA; Minnesota Supercomputing Institute, University of Minnesota, Minneapolis, MN, USA., Li Y; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA., Heer R; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Tyne and Wear, UK.; Translational and Clinical Research Institute, NU Cancer, Newcastle upon Tyne, Tyne and Wear, UK., Gaughan L; Translational and Clinical Research Institute, NU Cancer, Newcastle upon Tyne, Tyne and Wear, UK., Morris MJ; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Beltran H; Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Ryan CJ; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA., Antonarakis ES; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA., Armstrong AJ; Department of Medicine, Division of Medical Oncology, Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA., Halabi S; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA., Dehm SM; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA. dehm@umn.edu.; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA. dehm@umn.edu.; Department of Urology, University of Minnesota, Minneapolis, MN, USA. dehm@umn.edu.
Source: Nature communications [Nat Commun] 2024 Dec 11; Vol. 15 (1), pp. 10648. Date of Electronic Publication: 2024 Dec 11.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Research Support, U.S. Gov't, P.H.S.; Research Support, N.I.H., Extramural
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39663356
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patients.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Knutson+TP%22">Knutson TP</searchLink>; Minnesota Supercomputing Institute, University of Minnesota, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Luo+B%22">Luo B</searchLink>; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Kobilka+A%22">Kobilka A</searchLink>; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Lyman+J%22">Lyman J</searchLink>; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.; Graduate Program in Molecular, Cellular, and Developmental Biology and Genetics, University of Minnesota, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Guo+S%22">Guo S</searchLink>; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Munro+SA%22">Munro SA</searchLink>; Minnesota Supercomputing Institute, University of Minnesota, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Li+Y%22">Li Y</searchLink>; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Heer+R%22">Heer R</searchLink>; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Tyne and Wear, UK.; Translational and Clinical Research Institute, NU Cancer, Newcastle upon Tyne, Tyne and Wear, UK.<br /><searchLink fieldCode="AU" term="%22Gaughan+L%22">Gaughan L</searchLink>; Translational and Clinical Research Institute, NU Cancer, Newcastle upon Tyne, Tyne and Wear, UK.<br /><searchLink fieldCode="AU" term="%22Morris+MJ%22">Morris MJ</searchLink>; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Beltran+H%22">Beltran H</searchLink>; Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ryan+CJ%22">Ryan CJ</searchLink>; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Antonarakis+ES%22">Antonarakis ES</searchLink>; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Armstrong+AJ%22">Armstrong AJ</searchLink>; Department of Medicine, Division of Medical Oncology, Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Halabi+S%22">Halabi S</searchLink>; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Dehm+SM%22">Dehm SM</searchLink>; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA. dehm@umn.edu.; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA. dehm@umn.edu.; Department of Urology, University of Minnesota, Minneapolis, MN, USA. dehm@umn.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2024 Dec 11; Vol. 15 (1), pp. 10648. <i>Date of Electronic Publication: </i>2024 Dec 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Research Support, U.S. Gov't, P.H.S.; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39663356
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-024-54847-1
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 10648
    Titles:
      – TitleFull: AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patients.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Knutson TP
      – PersonEntity:
          Name:
            NameFull: Luo B
      – PersonEntity:
          Name:
            NameFull: Kobilka A
      – PersonEntity:
          Name:
            NameFull: Lyman J
      – PersonEntity:
          Name:
            NameFull: Guo S
      – PersonEntity:
          Name:
            NameFull: Munro SA
      – PersonEntity:
          Name:
            NameFull: Li Y
      – PersonEntity:
          Name:
            NameFull: Heer R
      – PersonEntity:
          Name:
            NameFull: Gaughan L
      – PersonEntity:
          Name:
            NameFull: Morris MJ
      – PersonEntity:
          Name:
            NameFull: Beltran H
      – PersonEntity:
          Name:
            NameFull: Ryan CJ
      – PersonEntity:
          Name:
            NameFull: Antonarakis ES
      – PersonEntity:
          Name:
            NameFull: Armstrong AJ
      – PersonEntity:
          Name:
            NameFull: Halabi S
      – PersonEntity:
          Name:
            NameFull: Dehm SM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 11
              M: 12
              Text: 2024 Dec 11
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1